105 related articles for article (PubMed ID: 20386753)
1. S100A1: a pluripotent regulator of cardiac and vascular function.
Desjardins JF; Teichert-Kuliszewska K; Parker T
Can J Cardiol; 2010 Mar; 26 Suppl A():9A-12A. PubMed ID: 20386753
[TBL] [Abstract][Full Text] [Related]
2. Endothelial S100A1 modulates vascular function via nitric oxide.
Pleger ST; Harris DM; Shan C; Vinge LE; Chuprun JK; Berzins B; Pleger W; Druckman C; Völkers M; Heierhorst J; Øie E; Remppis A; Katus HA; Scalia R; Eckhart AD; Koch WJ; Most P
Circ Res; 2008 Apr; 102(7):786-94. PubMed ID: 18292599
[TBL] [Abstract][Full Text] [Related]
3. S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.
Kraus C; Rohde D; Weidenhammer C; Qiu G; Pleger ST; Voelkers M; Boerries M; Remppis A; Katus HA; Most P
J Mol Cell Cardiol; 2009 Oct; 47(4):445-55. PubMed ID: 19538970
[TBL] [Abstract][Full Text] [Related]
4. S100A1: a multifaceted therapeutic target in cardiovascular disease.
Rohde D; Ritterhoff J; Voelkers M; Katus HA; Parker TG; Most P
J Cardiovasc Transl Res; 2010 Oct; 3(5):525-37. PubMed ID: 20645037
[TBL] [Abstract][Full Text] [Related]
5. S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.
Ritterhoff J; Völkers M; Seitz A; Spaich K; Gao E; Peppel K; Pleger ST; Zimmermann WH; Friedrich O; Fink RHA; Koch WJ; Katus HA; Most P
Mol Ther; 2015 Aug; 23(8):1320-1330. PubMed ID: 26005840
[TBL] [Abstract][Full Text] [Related]
6. S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function.
Völkers M; Rohde D; Goodman C; Most P
J Biomed Biotechnol; 2010; 2010():178614. PubMed ID: 20368797
[TBL] [Abstract][Full Text] [Related]
7. Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes.
Boerries M; Most P; Gledhill JR; Walker JE; Katus HA; Koch WJ; Aebi U; Schoenenberger CA
Mol Cell Biol; 2007 Jun; 27(12):4365-73. PubMed ID: 17438143
[TBL] [Abstract][Full Text] [Related]
8. The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes.
Remppis A; Most P; Löffler E; Ehlermann P; Bernotat J; Pleger S; Börries M; Reppel M; Fischer J; Koch WJ; Smith G; Katus HA
Basic Res Cardiol; 2002; 97 Suppl 1():I56-62. PubMed ID: 12479236
[TBL] [Abstract][Full Text] [Related]
9. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
[TBL] [Abstract][Full Text] [Related]
10. S100A1: a regulator of myocardial contractility.
Most P; Bernotat J; Ehlermann P; Pleger ST; Reppel M; Börries M; Niroomand F; Pieske B; Janssen PM; Eschenhagen T; Karczewski P; Smith GL; Koch WJ; Katus HA; Remppis A
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13889-94. PubMed ID: 11717446
[TBL] [Abstract][Full Text] [Related]
11. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.
Brinks H; Rohde D; Voelkers M; Qiu G; Pleger ST; Herzog N; Rabinowitz J; Ruhparwar A; Silvestry S; Lerchenmüller C; Mather PJ; Eckhart AD; Katus HA; Carrel T; Koch WJ; Most P
J Am Coll Cardiol; 2011 Aug; 58(9):966-73. PubMed ID: 21851887
[TBL] [Abstract][Full Text] [Related]
12. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.
Most P; Pleger ST; Völkers M; Heidt B; Boerries M; Weichenhan D; Löffler E; Janssen PM; Eckhart AD; Martini J; Williams ML; Katus HA; Remppis A; Koch WJ
J Clin Invest; 2004 Dec; 114(11):1550-63. PubMed ID: 15578088
[TBL] [Abstract][Full Text] [Related]
13. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
14. Post-translational S-nitrosylation is an endogenous factor fine tuning the properties of human S100A1 protein.
Lenarčič Živković M; Zaręba-Kozioł M; Zhukova L; Poznański J; Zhukov I; Wysłouch-Cieszyńska A
J Biol Chem; 2012 Nov; 287(48):40457-70. PubMed ID: 22989881
[TBL] [Abstract][Full Text] [Related]
15. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes.
Kettlewell S; Most P; Currie S; Koch WJ; Smith GL
J Mol Cell Cardiol; 2005 Dec; 39(6):900-10. PubMed ID: 16236309
[TBL] [Abstract][Full Text] [Related]
16. Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes.
Most P; Boerries M; Eicher C; Schweda C; Völkers M; Wedel T; Söllner S; Katus HA; Remppis A; Aebi U; Koch WJ; Schoenenberger CA
J Cell Sci; 2005 Jan; 118(Pt 2):421-31. PubMed ID: 15654019
[TBL] [Abstract][Full Text] [Related]
17. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes.
Völkers M; Loughrey CM; Macquaide N; Remppis A; DeGeorge BR; Wegner FV; Friedrich O; Fink RH; Koch WJ; Smith GL; Most P
Cell Calcium; 2007 Feb; 41(2):135-43. PubMed ID: 16919727
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.
Rohde D; Busch M; Volkert A; Ritterhoff J; Katus HA; Peppel K; Most P
Future Cardiol; 2015 May; 11(3):309-21. PubMed ID: 26021637
[TBL] [Abstract][Full Text] [Related]
19. S100A1: a major player in cardiovascular performance.
Duarte-Costa S; Castro-Ferreira R; Neves JS; Leite-Moreira AF
Physiol Res; 2014; 63(6):669-81. PubMed ID: 25157660
[TBL] [Abstract][Full Text] [Related]
20. S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.
Most P; Remppis A; Pleger ST; Katus HA; Koch WJ
Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R568-77. PubMed ID: 17459908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
